In pancreatic cancer, co-injecting CXCL13 and CCL21 into the tumors of a murine model drove TLS neogenesis and markedly enhanced the anti-tumor effects of chemotherapy [49]. The gene discussed is CXCL13; the disease is pancreatic neoplasm.